2024 Achievements

CRN closed Q4 2024 strong, marking an impactful year of work, including setting the record straight about the safety of prenatal vitamins, moving forward its litigation fighting for the industry’s First Amendment rights in relation to age restrictions, and much more. 

CRN continued its proactive work on multiple fronts, driving supplement industry initiatives, fighting back against age restriction proposals in the states, advocating for science-based policymaking in the U.S. and internationally at Codex, while supporting consumer access and responsible industry growth.

CRN led the industry in its strategically executed fight against an unconstitutional age restriction law that took effect in New York in April. In addition, the CRN team continued its work educating influential stakeholders about the value of dietary supplements in the second quarter.  Following is a brief recap of CRN’s impactful work for its members during Q2 in each of the areas of our strategic plan.

CRN’s thoughtful and expert execution of work driven by our board-developed strategic plan was well underway in the first quarter as the dietary supplement and functional food industry faced impending age restrictions on its products in New York, with other states also seeking to fill perceived gaps in regulation, and ongoing scrutiny from critics over melatonin and gummy supplements.